Search Results 421-430 of 17283 for egfr

1. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   Calculated creatinine clearance ≥ 60 mL/min using the following formula: eGFR × body surface area [BSA]/1.73 m2 (per the National Kidney Foundation eGFR ...

2. Early Feasibility Study Of HyperQureTM RDN System, Laparoscopic Renal Denervation Therapy, In Patients With Resistant Hypertension - Mayo Clinic

   Individual has an eGFR of <60 mL/min/1.73m2, using the 4 variable Modification of Diet in Renal Disease (MDRD) calculation (in mL/min) per 1.73 m2 = 175 x ...

3. End-stage renal disease - Doctors and departments - Mayo Clinic

   When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.

4. OBINUTUZUMAB in Treatment of Fibrillary Glomerulonephritis - Mayo Clinic

   eGFR ≥ 20 ml/min/BSA. Exclusion Criteria: Secondary FGN (due to monoclonal gammopathy, autoimmune disease or malignancy). Presence of a secondary pathology ...

5. Phase 1b Open-Label Study of PEGPH20 With Pembrolizumab - Mayo Clinic

   Subjects with NSCLC who are known to be epidermal growth factor receptor (EGFR)-mutation positive must have received an EGFR inhibitor and subjects known to ...

6. Early Feasibility Study of the Edwards FORMA Tricuspid Transcatheter Repair System - Mayo Clinic

   Kidney dysfunction with estimated Glomerular Filtration Rate (eGFR) < 30 ml/min/1.73 m2 or patient is on chronic dialysis. Any physical impairment which ...

7. INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure - Mayo Clinic

   Renal impairment (eGFR ≤ 60); History of ischemic stroke; History of peripheral artery disease; Current smoking. Exclusion Criteria: Known allergy ...

8. Seladelpar In Subjects With Primary Biliary Cholangitis (PBC) And Compensated Cirrhosis - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m^2. MELD score >12. For individuals on anticoagulation medication, baseline International ...

9. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting - Mayo Clinic

   ... (eGFR) < 30 mL/min/1.73m^2 at screening or within 90 days of screening using the Schwartz formula in participants < 18 years of age. Currently breastfeeding ...

10. A Phase 1 Study Of The Safety And Tolerability Of MT-125 In GBM Patients - Mayo Clinic

    Serum eGFR ≥60 ml/min 5. QTc 470 ms on triplicate 12 lead ECG ≤29 days prior to registration. NOTE: QTc intervals will be corrected using Fridericia's ...